Página 2 - Melhores Timoma médicos - TOP-58 médicos

A Prof.ª Elke Jaeger é uma das melhores oncologistas alemãs, de acordo com a classificação da Focus, especializada em sarcomas.

• Chefe de Oncologia e Hematologia na Clínica Nordwest
• Mais de 35 anos de experiência em oncologia
• Principal especialista no tratamento de sarcomas

O Dr. Alemdar é especialista no tratamento de timoma, com vasta experiência em oncologia médica nos principais hospitais turcos.

• Formado pela Universidade de Akdeniz – uma instituição médica de prestígio na Turquia
• Mais de 15 anos de experiência em oncologia e medicina interna
• Trabalha no Medical Park Antalya Hospital Complex – equipado com instalações avançadas para o tratamento do cancro
• Membro da Associação Turca de Oncologia Médica

O Dr. Yildiz especializa-se em timoma e tumores neuroendócrinos, com vasta investigação publicada em revistas médicas internacionais.

• Publicar mais de 17 estudos sobre condições oncológicas raras
• Experiência no diagnóstico e tratamento de casos complexos de timoma
• Trabalhar no Medipol Mega University Hospital – um centro de oncologia de referência

O Professor Ondzhel é especialista em oncocirurgia com foco em cancros colorretais e retais, realizando procedimentos complexos no Hospital Universitário Medipol Mega.

• Formado na Cleveland Clinic – líder em cirurgia colorretal
• Proctologista certificado pela Comissão Europeia com mais de 25 anos de experiência
• Investigação publicada sobre adenocarcinoma retal e ressecção de cancro multivisceral
• Chefe do Departamento de Cirurgia da Universidade Medipol de Istambul
• Membro fundador da Eurasian Colorectal Technologies Association

O Prof. Univ. Dr. Wolfgang Köstler é um especialista líder em terapias direcionadas para o cancro, com mais de duas décadas de experiência em oncologia médica.

• Especializar-se em cancro da mama e neoplasias ginecológicas
• Subchefe da Divisão Clínica de Oncologia da Universidade Médica de Viena
• Concentrar-se na terapia sistémica individualizada contra o cancro e na imunoterapia
• Investigação publicada sobre o desenvolvimento de biomarcadores e biologia tumoral

O Prof. Walter Klepetko foi pioneiro nos primeiros transplantes de pulmão na Áustria e estabeleceu um dos principais programas de cirurgia torácica da Europa na Universidade de Medicina de Viena.

• Mais de 40 anos de especialização em oncologia torácica complexa e transplante pulmonar
• Ex-Diretor de Cirurgia Torácica da Universidade de Medicina de Viena
• Desenvolver técnicas minimamente invasivas avançadas para tumores torácicos
• Renomado por lidar com casos de alto risco e ressecções complexas

O Dr. Felix Dobritoiu utiliza técnicas minimamente invasivas de ponta, como cirurgia robótica (da Vinci Xi) e VATS uniportal, para o tratamento de timoma no Ponderas Academic Hospital.

• Especializado em cirurgia torácica com experiência em ressecções mediastinais complexas
• Utilizar pequenas incisões para uma recuperação mais rápida e redução da dor pós-operatória
• Realizar procedimentos sem drenagem pleural pós-operatória, quando possível
• Treinado em técnicas avançadas, incluindo o procedimento de Nuss

O Prof. Associado Nail Paksoy traz sua experiência do Instituto de Oncologia da Universidade de Istambul e do Hospital Medipol Bahçelievler, com foco em timoma e outras malignidades torácicas.

• Certificado pela ESMO em Oncologia Médica desde 2022
• Redigir pesquisas sobre cancros torácicos raros publicadas em revistas internacionais
• Participar em 8 ensaios clínicos internacionais para novas terapias contra o cancro
• Especializar-se em imunoterapia e abordagens de terapia-alvo

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Mais de 30 anos de experiência em imunologia – A Dra. Jaunalksne é especialista em viroterapia, uma área de vanguarda no tratamento do timoma.

• Chefiar o Centro de Imunologia Clínica do Hospital Universitário Clínico Pauls Stradins
• Licenciar-se no Instituto de Medicina de Riga com estágio em Medicina Interna
• Focar-se em abordagens imunológicas inovadoras

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

O Dr. Erkan Karatas traz uma vasta formação internacional para o seu trabalho no Hospital Universitário Atlas, com especialização em otorrinolaringologia e cirurgia de cabeça e pescoço.

• Formação em instituições de prestígio em todo o mundo, incluindo a Universidade de Munique e a Universidade Estadual de Ohio
• Especialização em implantes cocleares e abordagens endoscópicas com formação pela empresa Medel
• Membro de múltiplas sociedades profissionais, incluindo a Academia Americana de Otorrinolaringologia
• Estudos avançados concluídos em otologia e neurotologia na Alemanha e nos EUA

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).